Akebia Therapeutics Inc. will release its financial results for the fourth quarter and full year 2025 on Wednesday, February 26, 2026, providing investors and analysts with a comprehensive overview of the company's operational and financial performance throughout the period.
Following the earnings release, the company will host a conference call beginning at 8:00 a.m. Eastern Standard Time to review the financial statements and discuss significant business developments. The call will offer stakeholders an opportunity to gain insight into the company's strategic direction and operational achievements during the fiscal year.
The announcement provides market participants advance notice to prepare for the earnings review and allows investors to schedule participation in the live discussion of results and company outlook.